SEC Form 4 · accession 0001354488-15-002805
PERNIX THERAPEUTICS HOLDINGS, INC. · PTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Joseph Golembiewski
Officer — VP Finance, Controller, CAO
Period of report
Apr 6, 2015
Accepted (ET)
Jun 1, 2015 · 3:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001024126
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options (right to buy)F1 | $10.51 | Apr 6, 2015 | A | 60,000 | A | Apr 6, 2016 | Apr 6, 2025 | Common Stock | 60,000 | 0 | D |
Explanation of responses
- F1The stock options vest in annual 15,000 share installments with the first installment vesting on the first anniversary of the date of the grant and the final installment vesting on the fourth anniversary thereof.